Plain Language Study Results Summaries
What Are Plain Language Study Results Summaries?
Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries (also called layperson summaries, plain language summaries, lay language summaries, simple summaries, and trial results summaries) are intended to make the clinical results of these studies understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.
Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials. For more information about a specific study, please visit ClinicalTrials.gov on the ClinicalTrials.gov Identifier (NCT) link on the study results page.
Category & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: PF-07038124
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 1
Medicine: PF-07081532
PrintDownloadCategory & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 1/2
Medicine: PF-07302048 (BNT162)
PrintDownloadCategory & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 2/3
Medicine: PF-07302048 (BNT162)
PrintDownloadCategory & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 1
Medicine: PF-07304814
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: ritlecitinib (PF-06651600)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 2
Medicine: vupanorsen (PF-07285557)
PrintDownloadCategory & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Zavicefta (ceftazidime-avibactam)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: ETRASIMOD
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: ETRASIMOD
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: abrilada (PF-06410293)
PrintDownloadCategory & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Fosmanogepix (PF-07842805)
PrintDownload